par Badr, Dominique
;Kassem, Chirine
;Carlin, Andrew
;Dobrescu, Oana Gabriela
;Iconaru, Laura
;Baleanu, Felicia
;Taujan, Georgiana Cristina;Jani, Jacques C
Référence Gynecological endocrinology, 38, 5, page (411-415)
Publication Publié, 2022-05-01
;Kassem, Chirine
;Carlin, Andrew
;Dobrescu, Oana Gabriela
;Iconaru, Laura
;Baleanu, Felicia
;Taujan, Georgiana Cristina;Jani, Jacques CRéférence Gynecological endocrinology, 38, 5, page (411-415)
Publication Publié, 2022-05-01
Article révisé par les pairs
| Résumé : | Following the adoption of the International Association of Diabetes and Pregnancy Study Group (IADPSG) criteria for gestational diabetes mellitus (GDM) diagnosis by the World Health Organization (WHO) in 2014, many investigators have tried to identify independent risk factors for antenatal insulin therapy (AIT). The purpose of the current study is to build and validate a score that stratifies patients according to their need for AIT. |



